MD, Medical
University of Navarra, Pamplona, Spain
Clinical Oncology
Hospital Clinic, Barcelona, Spain
ScM, Biostatistics
Autonomous University of Barcelona, Barcelona, Spain
ScM, Epidemiology
Harvard T.H. Chan School of Public Health, Boston, MA
PhD, Medicine
University of Barcelona, Barcelona, Spain
Xabier García de Albéniz currently collaborates on several academic research projects in the field of cancer comparative effectiveness and development of methods for cancer research and COVID-19 prophylaxis. Dr. García de Albéniz provides oncology and methodologic expertise in epidemiology at RTI HS and has a background in oncology, epidemiology, and biostatistics. Dr. García de Albéniz trained as a clinical oncologist in Barcelona while pursuing a Master’s degree in biostatistics and has worked for several years within the Program on Causal Inference, Department of Epidemiology at the Harvard T.H. Chan School of Public Health, where he maintains an affiliation as a visiting scientist and collaborator of the CAUSALab.